Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 39.03 | N/A |
| PEG Ratio (TTM) | 0.14 | N/A |
| P/S Ratio (TTM) | 0.92 | N/A |
| P/B Ratio (TTM) | 1.58 | N/A |
| P/FCF Ratio (TTM) | 11.10 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.60 | N/A |
| Price to 5YR AVG FCF Ratio | 23.66 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.25% | N/A |
| ROE (TTM) | 4.26% | N/A |
| Net Profit Margin (TTM) | 2.37% | N/A |
| ROIC 5YR AVG | 13.15% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 574.56% | 218.30% | 113.13% |
| Revenue | 0.73% | -6.90% | -2.37% |
| Net Income | 580.47% | 230.81% | 115.07% |
| Cash Flow | 37.14% | 205.66% | 128.66% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.17 | N/A |
| Quick Ratio (TTM) | 1.14 | N/A |
| D/E Ratio (TTM) | 0.31 | N/A |
| Interest Coverage (TTM) | 3.63 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.96 | N/A |
| LTL to 5YR AVG FCF | 5.51 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.15% | N/A |